Sham radiation in clinical trials assessing radiotherapy for exudative age-related macular degeneration

Retina

Volumn 19, Issue 6, 1999, Pages 525-530

  Marcus, Dennis M ^a   Camp, Matthew W ^b   Sheils, W Chris ^a   McIntosh, Sandra B ^a   Leibach, Diane B ^a   Johnson, Maribeth H ^a   Samy, Chander N ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b PIEDMONT HOSPITAL   (United States)

^c Ocala Eye Surgeons   (United States)

Author keywords

Age related macular degeneration; Choroidal neovascularization; External beam irradiation; Masking; Placebo; Radiotherapy; Randomized clinical trial; Sham radiation

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASKING; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0033512396     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-199919060-00008     Document Type: Article

References (17)

1. Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol 1993;77:265-273.
2. Bergink GJ, Deutman AF, Van Den Broek JECM, et al. Radiation therapy for age-related subfoveal choroidal neovascular membranes. Doc Ophthalmol 1995;90:67-74.
3. Finger PT, Berson A, Sherr D, et al. Radiation therapy for subretinal neovascularization. Ophthalmology 1996;103:878-889.
4. Berson AM, Finger PT, Sherr DL, et al. Radiotherapy for age-related macular degeneration: preliminary results of a potentially new treatment. Int J Radiat Oncol Biol Phys 1996; 36:861-865.
5. Freire J, Longton WA, Miyamoto CT, et al. External radiotherapy in macular degeneration: technique and preliminary subjective response. Int J Radiat Oncol Biol Phys 1996;36: 857-860.
6. Hart PM, et al. Teletherapy for subfoveal choroidal neovascularization of age-related macular degeneration: results of follow-up in a non-randomized study. Br J Ophthalmol 1996;80: 1046-1050.
7. Hart PM, Archer DB, Chakravarthy U. Asymmetry of disciform scarring in bilateral disease when one eye is treated with radiotherapy. Br J Ophthalmol 1995;79:562-568.
8. Yonemoto LT, Slater JD, Friedrichsen EJ. Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: treatment techniques and preliminary results. Int J Radiat Oncol Biol Phys 1996;36:867-871.
9. Spaide RF, Guyer DR, McCormick B, et al. External beam radiation therapy for choroidal neovascularization. Ophthalmology 1998;105:24-30.
10. Stalmans P, Leys A, Van Limbergen E. External beam radiotherapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularization in age-related macular degeneration: a review of 111 cases. Retina 1997;17:481-492.
11. Postgens H, Bodanowitz S, Kroll P. Low-dose radiation therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1997;235:656-661.
12. Bergink GJ, Hoyng CB, van der Maazen RWM. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation. Graefes Arch Clin Exp Ophthalmol 1998;236:321-325.
13. Marcus DM, Sheils C, Burch S, et al. The Radiation of Age-Related Macular Degeneration (ROARMD) Study [abstract]. Invest Ophthalmol Vis Sci 1996;37(suppl):1016.
14. Chakravarthy U. Radiation therapy for age-related macular degeneration [letter]. JAMA 1997;278:288-289.
15. Zar JH. Biostatistical Analysis, ed 2. Englewood Cliffs, NJ: Prentice Hall, 1984:378.
16. Pharmacological Therapy for Macular Degeneration Study Group. Interferon alpha-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997;115:865-872.
17. Prummel MF, Mourits MP, Blank L, Berghout A, Koornneef L, Wiersinga WM. Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993;342:949-954.